Single Country Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis Patients Treated With BG00012
Phase of Trial: Phase III
Latest Information Update: 02 May 2017
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms StarTec
- Sponsors Biogen
- 02 Feb 2017 Status changed from active, no longer recruiting to completed.
- 22 Sep 2016 Planned End Date changed from 1 Feb 2017 to 1 Oct 2016.
- 22 Sep 2016 Planned primary completion date changed from 1 Feb 2017 to 1 Oct 2016.